Drugmaker paying $33M over recalled nonprescription meds

Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold nonprescription medicines that didn't meet federal quality requirements.The settlement was announced Wednesday by attorneys general from the states. The case dates to 2009, when Johnson & Johnson began dozens of voluntary recalls of popular over-the-counter medicines for children and adults, including Tylenol, Motrin and Benadryl.Those and several other products made at